Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fabian Fernandez,Wade Morishita,Elizabeth Zuniga,James Nguyen,Martina Blank,Robert C Malenka,Craig C Garner
DOI: https://doi.org/10.1038/nn1860
IF: 25
2007-02-25
Nature Neuroscience
Abstract:Ts65Dn mice, a model for Down syndrome, have excessive inhibition in the dentate gyrus, a condition that could compromise synaptic plasticity and mnemonic processing. We show that chronic systemic treatment of these mice with GABAA antagonists at non-epileptic doses causes a persistent post-drug recovery of cognition and long-term potentiation. These results suggest that over-inhibition contributes to intellectual disabilities associated with Down syndrome and that GABAA antagonists may be useful therapeutic agents for this disorder.
neurosciences
What problem does this paper attempt to address?